TP53 and acute myeloid leukemia: The majority of identified cases of AML-EMD fall into AML with mutated TP53 (when mutational analysis was performed) or AML-MRC, with the exception of two cases occurring in patients with Down syndrome and Schwachman-Diamond syndrome respectively [3, 6].